Cargando…
Circulating trimethylamine N‐oxide levels do not predict 10‐year survival in patients with or without coronary heart disease
BACKGROUND: Trimethylamine N‐oxide (TMAO) is an amine oxide generated by gut microbial metabolism. TMAO may contribute to atherothrombosis and systemic inflammation. However, the prognostic value of circulating TMAO for risk stratification is uncertain. METHODS: We assessed prospective relationships...
Autores principales: | Bjørnestad, Espen Ø., Dhar, Indu, Svingen, Gard F. T., Pedersen, Eva R., Ørn, Stein, Svenningsson, Mads M., Tell, Grethe S., Ueland, Per M., Sulo, Gerhard, Laaksonen, Reijo, Nygård, Ottar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804190/ https://www.ncbi.nlm.nih.gov/pubmed/35916742 http://dx.doi.org/10.1111/joim.13550 |
Ejemplares similares
-
Trimethyllysine predicts all-cause and cardiovascular mortality in community-dwelling adults and patients with coronary heart disease
por: Bjørnestad, Espen Ø, et al.
Publicado: (2021) -
Plasma Cystathionine and Risk of Incident Stroke in Patients With Suspected Stable Angina Pectoris
por: Dhar, Indu, et al.
Publicado: (2018) -
Neopterin as an Effect Modifier of the Cardiovascular Risk Predicted by Total Homocysteine: A Prospective 2‐Cohort Study
por: Bjørnestad, Espen Ø., et al.
Publicado: (2017) -
B-vitamin Treatment Modifies the Mortality Risk Associated with Calcium Channel Blockers in Patients with Suspected Stable Angina Pectoris: A Prospective Cohort Study
por: Dhar, Indu, et al.
Publicado: (2023) -
Physical activity and risk of all-cause mortality in patients with stable angina pectoris: Effect modification by β-blocker treatment
por: Dhar, Indu, et al.
Publicado: (2022)